Christopher Paul Hancock Purchases 4,712 Shares of Creo Medical Group PLC (LON:CREO) Stock

Creo Medical Group PLC (LON:CREO) insider Christopher Paul Hancock purchased 4,712 shares of the stock in a transaction dated Monday, January 20th. The shares were acquired at an average price of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,102.15).

Creo Medical Group Trading Down 3.1 %

Shares of CREO stock opened at GBX 17.45 ($0.21) on Thursday. Creo Medical Group PLC has a 1-year low of GBX 12 ($0.15) and a 1-year high of GBX 43 ($0.53). The firm has a market cap of £63.13 million, a PE ratio of -290.83 and a beta of 0.86. The company has a 50-day moving average of GBX 17.54 and a two-hundred day moving average of GBX 23.40. The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.